SANDOZ TOFACITINIB
SANDOZ CANADA INCORPORATED
Quick answers
Is there a shortage of SANDOZ TOFACITINIB in Canada?
No. There is no current shortage of SANDOZ TOFACITINIB 10MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
TARO-TOFACITINIB
TARO PHARMACEUTICALS INC
Other Products
XELJANZ
PFIZER CANADA ULC
SANDOZ TOFACITINIB
SANDOZ CANADA INCORPORATED
TARO-TOFACITINIB XR
Extended-ReleaseTARO PHARMACEUTICALS INC
PMS-TOFACITINIB
PHARMASCIENCE INC
XELJANZ XR
Extended-ReleasePFIZER CANADA ULC
DIN
02551705
Strength
10MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
TOFACITINIB (TOFACITINIB CITRATE)
See all TOFACITINIB (TOFACITINIB CITRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759